Nevertheless,the data available to date regarding PPARγ are promising and justify engaging in clinicalstudies to determine the true role of PPARγ ligands in lung cancer, while further work shouldbe performed to identify more selective and effective strategies. This evidence concerns the gene PPARG and lung carcinoma.